The Ontario College is set to develop a standard for the requirement, which will be presented at the next board meeting in March 2023 and will come into effect immediately after approval.
Canadian researchers recently developed the Antidepressant Decision Support Tool to assist primary care practitioners in individualizing first-line pharmacotherapy for major depressive disorder.
Demand for semaglutide spiked after Musk tweeted that Wegovy helped him lose weight. That's a problem for patients with Type 2 diabetes or obesity who can't fill their prescriptions.